慢性肾脏病患者并发结核病临床特点分析

doi:10.19871/j.cnki.xfcrbzz.2023.01.011

新发传染病电子杂志 ›› 2023, Vol. 8 ›› Issue (1): 52-55.doi: 10.19871/j.cnki.xfcrbzz.2023.01.011

慢性肾脏病患者并发结核病临床特点分析

任坦坦¹, 詹森林¹, 张培泽¹, 汤全珍², 徐正富³, 王凌伟⁴, 付亮¹, 邓国防¹

1.南方科技大学附属深圳市第三人民医院肺二科,广东深圳 518112;
2.深圳大学总医院感染科,广东深圳 518055;
3.深圳市中医院肾内科,广东深圳 518033;
4.深圳市人民医院呼吸内科,广东深圳 518020

收稿日期:2021-12-13 出版日期:2023-02-28 发布日期:2023-03-30
通讯作者: 邓国防,Email:jxxk1035@yeah.net
基金资助:
“十三五”国家科技重大专项（2018ZX10715004-002-007）

Analysis on characteristics of tuberculosis in patients with chronic kidney disease

Ren Tantan¹, Zhan SenLin¹, Zhang Peize¹, Tang Quanzhen², Xu Zhengfu³, Wang Lingwei⁴, Fu Liang¹, Deng Guofang¹

1. Second Department of Pulmonary Medicine, Shenzhen Third People's Hospital Affiliated to Southern University of Science and Technology, Guangdong Shenzhen 518112, China;
2. Department of Infectious Diseases, General Hospital of Shenzhen University, Guangdong Shenzhen 518055, China;
3. Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, Guangdong Shenzhen 518033, China;
4. Department of Respiratory Medicine, Shenzhen People's Hospital, Guangdong Shenzhen 518020, China

Received:2021-12-13 Online:2023-02-28 Published:2023-03-30

摘要/Abstract

摘要： 目的回顾性分析慢性肾脏病患者的结核病发生和预后,探讨慢性肾脏病患者并发结核病的临床特点。方法选取2013年1月至2017年12月南方科技大学附属深圳市第三人民医院、深圳大学总医院、深圳市中医院、深圳市人民医院4家医院肾内科与血液净化中心接受慢性肾脏病治疗和透析治疗3个月以上的患者4195例,分为两组,终末期肾病（ESRD）组1169例：肾小球滤过率<15ml/（min·1.73m²）;非终末期肾病（no-ESRD）组3206例：肾小球滤过率≥15ml/（min·1.73m²）,且满足慢性肾脏病的诊断标准,回顾性分析两组患者的结核病发生率、临床特征及预后。结果 ESRD组1169例中有57例（4.9%）诊断为活动性结核,其中肺结核36例（63.2%）,肺外结核14例（24.6%）,肺结核合并肺外结核者7例（12.3%）,全因死亡率为8.8%（5/57）。no-ESRD组3026例患者中,有69例（2.3%）诊断为活动性结核,其中肺结核47例（68.1%）,肺外结核16例（23.2%）,肺结核合并肺外结核6例（8.7%）,全因死亡率为2.9%（2/69）。 ESRD组与no-ESRD组比较,发病率和病因分布差异有统计学意义（χ²=19.502、10.076,P=0.000、0.018）;而两组患者免疫学检测、结核类型、临床预后方面差异无统计学意义（χ²=0.222、0.530、3.971,P=0.974、0.767、0.137）。结论慢性肾脏病患者并发结核病发生率高,以ESRD患者为甚。迫切需要对慢性肾脏病患者进行结核病筛查,以及时诊断和治疗。

关键词: 血液透析, 腹膜透析, 肾功能不全, 肺结核, 肺外结核, 预后

Abstract: Objective To retrospectively analyze the incidence and prognosis of tuberculosis in patients with chronic kidney disease（CKD）, and to investigate the characteristics of tuberculosis in patients with CKD. Method Patients who received CKD treatment and dialysis treatment for more than 3 months in the nephrology department and blood purification center of four hospitals in Shenzhen from January 2013 to December 2017 were divided into 2 groups, ESRD group（end-stage renal disease,ESRD): glomerular filtration rate <15ml/(min·1.73m²); no-ESRD group（non-end-stage renal disease,no-ESRD): glomerular filtration rate ≥15ml/(min·1.73m²), and all patients meet the diagnostic criteria for CKD. The incidence, clinical features and prognosis of tuberculosis in these patients were retrospectively analyzed. Result There were 1169 and 3026 patients in the ESRD group and no-ESRD group respectively. Fifty-seven patients (4.9%) with active pulmonary tuberculosis were diagnosed in the ESRD group,of which 36 patients (63.2%) with pulmonary tuberculosis, 14 patients (24.6%) with extrapulmonary tuberculosis, 7 patients (12.3%) with pulmonary tuberculosis complicated extrapulmonary tuberculosis. The all-cause mortality rate was 8.8% (5/57) in the ESRD group. Sixty-nine patients (2.3%) with active tuberculosis were diagnosed in the no-ESRD group, of which 47 patients (68.1%) with pulmonary tuberculosis, 16 patients (23.2%) with extrapulmonary tuberculosis, and 6 patients (8.7%) with pulmonary tuberculosis complicated extrapulmonary tuberculosis.The all-cause mortality rate was 2.9% (2/69) in the no-ESRD group. Comparing the two groups of ESRD and no-ESRD, the incidence and etiology distribution are statistically significant (χ²=19.502、10.076,P=0.000、0.018); But there was no statistical difference between the two groups in immunological detection, tuberculosis type, and clinical prognosis (χ²=0.222、0.530、3.971,P=0.974、0.767、0.137). Conclusion The incidence of tuberculosis in patients with CKD is high, especially in ESRD patients. There is an urgent need screening tuberculosis for timely diagnosis and treatment in patients with CKD.

Key words: Hemodialysis, Peritoneal dialysis, Renal insufficiency, Tuberculosis, Extrapulmonary tuberculosis, Prognosis

中图分类号:

任坦坦, 詹森林, 张培泽, 汤全珍, 徐正富, 王凌伟, 付亮, 邓国防. 慢性肾脏病患者并发结核病临床特点分析[J]. 新发传染病电子杂志, 2023, 8(1): 52-55.

Ren Tantan, Zhan SenLin, Zhang Peize, Tang Quanzhen, Xu Zhengfu, Wang Lingwei, Fu Liang, Deng Guofang. Analysis on characteristics of tuberculosis in patients with chronic kidney disease[J]. Electronic Journal of Emerging Infectious Diseases, 2023, 8(1): 52-55.

参考文献

[1] 卢春容,房宏霞,陆普选,等.2021 WHO全球结核病报告:全球与中国关键数据分析[J/CD].新发传染病电子杂志,2021,6(4):368-372.
[2] 中国医院协会血液净化中心管理分会专家组. 中国成人慢性肾脏病合并结核病管理专家共识[J]. 中国血液净化, 2016(11):577-586.
[3] RAO TM, RAM R, SWARNALATHA G.et al.Tuberculosis in haemodialysis patients: A single centre experience[J].Indian J Nephrol, 2013, 23(5):340-345.
[4] PRADHAN RR, SIGDEL MR. Prevalence, Clinical Presentation,Outcome of Tuberculosis in Patients with Chronic Kidney Disease at a Tertiary Care Hospital in Nepal[J].Int J Nephrol, 2020, 2020:7401541.
[5] 中华人民共和国国家卫生和计划生育委员会.结核病分类(WS196—2017)[J/CD]. 新发传染病电子杂志,2018,3(3):191-192.
[6] STEVENA PE, LEVIN A.Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members; Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline[J]. Ann Intern Med, 2013, 158(11):825-830.
[7] CHANG KC, LEUNG CC.Systematic review of interferon-gamma release assays in tuberculosis: focus on likelihood ratios[J]. Thorax, 2010, 65(3): 271-276.
[8] KURTS C, PANZER U, ANDERS HJ, et al.The immune system and kidney disease:basic concepts and clinical implications[J]. Nat Rev Immunol, 2013,13(10):738-753.
[9] HILL NR, FATOBA ST, OKE JL, et al.Global Prevalence of Chronic Kidney Disease -A Systematic Review and Meta-Analysis[J]. PLoS One, 2016, 11(7): e158765.
[10] RUZANGI J, IWAGAMI M, SMEETH L, et al.The association between chronic kidney disease and tuberculosis; a comparative cohort study in England[J]. BMC Nephrol, 2020, 21(1): 420.
[11] CHO PJ, WU CY, IOHNSTON J, et al.Progression of chronic kidney disease and the risk of tuberculosis: an observational cohort study[J]. Int J Tuberc Lung Dis, 2019, 23(5):555-562.
[12] AL-EFRAIJ K, MOTA L, LUNNY C, et al.Risk of active tuberculosis in chronic kidney disease: a systematic review and meta-analysis[J]. Int J Tuberc Lung Dis, 2015, 19(12):1493-1499.
[13] MIN J, KWON SK, JEONG HW, et al.End-stage Renal Disease and Risk of Active Tuberculosis: a Nationwide Population-Based Cohort Study[J]. J Korean Med Sci, 2018, 33(53):e341.
[14] FERGUSON TW, TANGRI N, MACDONALD K, et al.The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and meta-analysis[J]. Transplantation, 2015, 99(5): 1084-1091.
[15] SEGALL L, COVIC A.Diagnosis of tuberculosis in dialysis patients: current strategy[J]. Clin J Am Soc Nephrol, 2010, 5(6): 1114-1122.
[16] EL KD, BAHADI A, OUALIM Z.Prevalence of tuberculosis in hemodialysis patients[J]. Saudi J Kidney Dis Transpl, 2010, 21(1): 164-167.

慢性肾脏病患者并发结核病临床特点分析

Analysis on characteristics of tuberculosis in patients with chronic kidney disease

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李金沛, 叶涛生, 徐宇翔, 曾旋, 刘志超, 杨倩婷. 儿童肺结核患者支气管肺泡灌洗液免疫细胞检测与分析[J]. 新发传染病电子杂志, 2023, 8(1): 14-18.
[2]	李同霞, 褚晏, 林梅, 李菁, 王丙瑞, 马广仁. 6765例结核分枝杆菌培养阳性肺结核患者耐药及共病分析[J]. 新发传染病电子杂志, 2022, 7(4): 12-15.
[3]	梁佳圆, 邬小萍, 杨丽霞, 蔡天盼, 王亮, 程齐齐, 孙俊, 刘丽萍, 甘厦, 阮宁杭, 葛善飞. 多种模型预测HBV-ACLF合并IPA患者的短期预后价值分析[J]. 新发传染病电子杂志, 2022, 7(4): 20-24.
[4]	桂静, 杨慧, 傅钰, 刘涛. 血糖血脂异常对肺结核合并2型糖尿病的影响分析[J]. 新发传染病电子杂志, 2022, 7(4): 37-41.
[5]	符雄, 符林琳, 符秋叶, 吴伟珍. T细胞斑点试验与痰涂片检查在成人不同年龄段肺结核诊断中的结果分析[J]. 新发传染病电子杂志, 2022, 7(4): 53-56.
[6]	王晓霞, 梁瑞云, 钟鹏. 儿童甲状腺癌肺转移误诊血行播散性肺结核3例报道[J]. 新发传染病电子杂志, 2022, 7(4): 82-85.
[7]	付寒, 王鹏, 张宗华, 季乐财. 标准抗结核治疗方案对耐多药肺结核患者肾功能的影响分析[J]. 新发传染病电子杂志, 2022, 7(3): 32-36.
[8]	郑广平, 罗杰棋, 鲍晓慧, 陆普选, 魏方军. 肠结核的临床影像诊断及与克罗恩病的鉴别诊断[J]. 新发传染病电子杂志, 2022, 7(3): 90-94.
[9]	宋敏, 谢智恩, 杨宏志, 吴华强, 官权, 钟鹏, 方伟军. 基于术前CT图像的放射组学模型预测脊柱结核手术治疗预后的研究[J]. 新发传染病电子杂志, 2022, 7(2): 52-56.
[10]	张爱平, 梁曼曼, 王子健, 王文节, 杨江华. 对比分析蜱传人和人传人致发热伴血小板减少综合征的临床特征及预后[J]. 新发传染病电子杂志, 2022, 7(1): 26-29.
[11]	张娟娟, 王云霞, 胡方祥, 黄佩佩, 刘振扬, 梅金周, 袁青. 自回归移动平均模型在深圳市宝安区结核病疫情预测中的应用[J]. 新发传染病电子杂志, 2022, 7(1): 47-51.
[12]	张小其, 李敏璐, 刘靖元. 互联网+视频服药APP督导方式在肺结核患者治疗管理中的应用效果[J]. 新发传染病电子杂志, 2022, 7(1): 66-69.
[13]	杨梁梓, 任坦坦, 傅向东, 刘智, 罗蓝, 张培泽. 含贝达喹啉新方案治疗耐药肺结核的疗效与安全性研究[J]. 新发传染病电子杂志, 2021, 6(4): 302-305.
[14]	黎惠如, 方伟军, 刘曾维, 谢智恩. CT在单发结节或肿块型肺结核和肺癌鉴别中的作用研究[J]. 新发传染病电子杂志, 2021, 6(4): 323-326.
[15]	谭运彩, 袁媛, 杨双喜, 杨雪. 二甲双胍与2型糖尿病患者肺结核感染风险的倾向性评分匹配分析[J]. 新发传染病电子杂志, 2021, 6(3): 202-205.